- Home
- NSPR
NSPR
InspireMD Inc.
as 11-14-2024 12:36pm EST
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
| Founded: | 2005 | Country: | Israel |
| Employees: | N/A | City: | TEL AVIV |
| Market Cap: | 63.0M | IPO Year: | N/A |
| Target Price: | $4.50 | AVG Volume (30 days): | 36.4K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.81 - $3.42 | Next Earning Date: | 11-12-2024 |
| Revenue: | $6,821,000 | Revenue Growth: | 24.70% |
| Revenue Growth (this year): | 12.28% | Revenue Growth (next year): | 53.44% |
Latest InspireMD Inc. News
NSPR Breaking Stock News: Dive into NSPR Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023)
GuruFocus.com
2 days ago
InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...
GlobeNewswire
3 days ago
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
GuruFocus.com
4 days ago
What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings
GlobeNewswire
6 days ago
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
11 days ago
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th
Simply Wall St.
25 days ago
One InspireMD Insider Raised Stake By 13% In Previous Year
GlobeNewswire
a month ago
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
Compare NSPR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NSPR InspireMD Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.